Notably, the latest progress demonstrated that JQ1 modulates tumour immune microenvironment (TIME) by suppressing constitutively PD‐L1 expression and interferon gamma (IFN‐γ)‐stimulated PD‐L1 expression in tumours,22, 23, 24, 25 eliciting tumour immunogenicity,26 improving activity of T cell24, 27 and natural killer (NK) cell.28 The gene discussed is IFNG; the disease is neoplasm.